Pacemaker Market Analysis By Product (Implantable, External), By Region {(North America (U.S., Canada), Europe (UK, Germany), Asia Pacific (Japan, China), Latin America (Brazil, Mexico), MEA (South Africa, Saudi Arabia)}, And Segment Forecasts, 2014 - 2025
The global pacemaker market is expected to reach USD 12.3 billion by 2025, according to a new report by Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled with the availability of medical coverage is a key driving factor governing the growth of Pacemaker globally. In addition, technological enhancements in these devices are supporting the expansion of this vertical.
Increasing prevalence of Cardiovascular Diseases (CVDs) is a high-impact growth rendering driver for this market. A death estimate of 17.5 million stemming from CVDs was reported by the World Health Organization in 2012. Currently, the high occurrence of CVDs is one of the key concern areas, to address which, government organizations and market participants are channelizing funds and efforts to offer the best possible cure. This is anticipated to foster R&D initiatives and increase the influx of advanced products in this space.
Additionally, increasing awareness about cardiovascular disorders and their long-term impact is increasing the preference of patients for advanced treatment options. This is expected to bolster the usage rate of these products.
On the other hand, these devices are cost prohibitive with the cost of pacemaker ranging from USD 10,000 to USD 30,000. The high price is likely to restrain the growth of the pacemaker market.
Further key findings from the study suggest:
Implantable pacemakers held a lucrative share in 2015 and are also likely to grow at a profitable rate over the forecast period
North America owing to its planned healthcare network, greater per capita income, and increasing awareness levels about the adverse effects of a prolonged cardiac condition helped this regional segment retain a sturdy share in the global pacemaker market
Economic development in countries, such as India and China, unmet needs of the huge population chunk, and supportive initiatives undertaken by the government to improve healthcare access is projected to present avenues for investment, thereby boosting the growth of the Asia Pacific region
Some of the key players operating in this space are Medtronic, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, ZOLL Medical Corporation, MEDICO S.p.A., Vitatron, Pacetronix, and Cordis, Inc.
Increasing prevalence of Cardiovascular Diseases (CVDs) is a high-impact growth rendering driver for this market. A death estimate of 17.5 million stemming from CVDs was reported by the World Health Organization in 2012. Currently, the high occurrence of CVDs is one of the key concern areas, to address which, government organizations and market participants are channelizing funds and efforts to offer the best possible cure. This is anticipated to foster R&D initiatives and increase the influx of advanced products in this space.
Additionally, increasing awareness about cardiovascular disorders and their long-term impact is increasing the preference of patients for advanced treatment options. This is expected to bolster the usage rate of these products.
On the other hand, these devices are cost prohibitive with the cost of pacemaker ranging from USD 10,000 to USD 30,000. The high price is likely to restrain the growth of the pacemaker market.
Further key findings from the study suggest:
Implantable pacemakers held a lucrative share in 2015 and are also likely to grow at a profitable rate over the forecast period
North America owing to its planned healthcare network, greater per capita income, and increasing awareness levels about the adverse effects of a prolonged cardiac condition helped this regional segment retain a sturdy share in the global pacemaker market
Economic development in countries, such as India and China, unmet needs of the huge population chunk, and supportive initiatives undertaken by the government to improve healthcare access is projected to present avenues for investment, thereby boosting the growth of the Asia Pacific region
Some of the key players operating in this space are Medtronic, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, ZOLL Medical Corporation, MEDICO S.p.A., Vitatron, Pacetronix, and Cordis, Inc.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
CHAPTER 3. PACEMAKER MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, By Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis - Porter’s
CHAPTER 4. PACEMAKER: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Pacemaker Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following products:
4.2.1. Implantable
4.2.1.1. Single Chamber
4.2.1.2. Dual Chamber
4.2.1.3. Biventricular
4.2.2. External
CHAPTER 5. PACEMAKER: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Pacemaker Movement Analysis & Market Share, 2015 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.3. Europe
5.3.1. UK
5.3.1.1. UK revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Japan
5.4.1.1. Japan revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.4.2. China
5.4.2.1. China revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. Medtronic
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. BIOTRONIK
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Boston Scientific Corporation
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. St. Jude Medical
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. ZOLL Medical Corporation
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. Vitatron
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. MEDICO S.p.A.
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Pacetronix
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Cordis, Inc.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
CHAPTER 3. PACEMAKER MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, By Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis - Porter’s
CHAPTER 4. PACEMAKER: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Pacemaker Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following products:
4.2.1. Implantable
4.2.1.1. Single Chamber
4.2.1.2. Dual Chamber
4.2.1.3. Biventricular
4.2.2. External
CHAPTER 5. PACEMAKER: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Pacemaker Movement Analysis & Market Share, 2015 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.3. Europe
5.3.1. UK
5.3.1.1. UK revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Japan
5.4.1.1. Japan revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.4.2. China
5.4.2.1. China revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia revenue estimates and forecasts by, product 2014 - 2025 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. Medtronic
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. BIOTRONIK
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Boston Scientific Corporation
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. St. Jude Medical
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. ZOLL Medical Corporation
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. Vitatron
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. MEDICO S.p.A.
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Pacetronix
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Cordis, Inc.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
LIST OF TABLES
1. North America pacemaker market, by product, 2014 - 2025 (USD Million)
2. U.S. pacemaker market, by product, 2014 - 2025 (USD Million)
3. Canada pacemaker market, by product, 2014 - 2025 (USD Million)
4. Europe pacemaker market, by product, 2014 - 2025 (USD Million)
5. UK pacemaker market, by product, 2014 - 2025 (USD Million)
6. Germany pacemaker market, by product, 2014 - 2025 (USD Million)
7. Asia Pacific pacemaker market, by product, 2014 - 2025 (USD Million)
8. Japan pacemaker market, by product, 2014 - 2025 (USD Million)
9. China pacemaker market, by product, 2014 - 2025 (USD Million)
10. Latin America pacemaker market, by product, 2014 - 2025 (USD Million)
11. Brazil pacemaker market, by product, 2014 - 2025 (USD Million)
12. Mexico pacemaker market, by product, 2014 - 2025 (USD Million)
13. MEA pacemaker market, by product, 2014 - 2025 (USD Million)
14. South Africa pacemaker market, by product, 2014 - 2025 (USD Million)
15. Saudi Arabia pacemaker market, by product, 2014 - 2025 (USD Million)
1. North America pacemaker market, by product, 2014 - 2025 (USD Million)
2. U.S. pacemaker market, by product, 2014 - 2025 (USD Million)
3. Canada pacemaker market, by product, 2014 - 2025 (USD Million)
4. Europe pacemaker market, by product, 2014 - 2025 (USD Million)
5. UK pacemaker market, by product, 2014 - 2025 (USD Million)
6. Germany pacemaker market, by product, 2014 - 2025 (USD Million)
7. Asia Pacific pacemaker market, by product, 2014 - 2025 (USD Million)
8. Japan pacemaker market, by product, 2014 - 2025 (USD Million)
9. China pacemaker market, by product, 2014 - 2025 (USD Million)
10. Latin America pacemaker market, by product, 2014 - 2025 (USD Million)
11. Brazil pacemaker market, by product, 2014 - 2025 (USD Million)
12. Mexico pacemaker market, by product, 2014 - 2025 (USD Million)
13. MEA pacemaker market, by product, 2014 - 2025 (USD Million)
14. South Africa pacemaker market, by product, 2014 - 2025 (USD Million)
15. Saudi Arabia pacemaker market, by product, 2014 - 2025 (USD Million)
LIST OF FIGURES
1. Market summary
2. Market trends & outlook
3. Market segmentation & scope
4. Market driver relevance analysis (Current & Future Impact)
5. Market restraint relevance analysis (Current & Future Impact)
6. Penetration & growth prospect mapping
7. Healthcare predictive analytics PEST by SWOT analysis
8. Porter’s five forces analysis
9. Pacemaker market application outlook key takeaways
10. Pacemaker: Product movement analysis
11. Implantable pacemaker market 2014 - 2025 (USD Million)
12. Single chambered pacemaker market 2014 - 2025 (USD Million)
13. Dual chamber pacemaker market 2014 - 2025 (USD Million)
14. Biventricular pacemaker market 2014 - 2025 (USD Million)
15. Regional market place: Key takeaways
16. Regional outlook, 2015 & 2025
17. North America pacemaker market, 2014 - 2025 (USD Million)
18. U.S. pacemaker market, 2014 - 2025 (USD Million)
19. Canada pacemaker market, 2014 - 2025 (USD Million)
20. Europe pacemaker market, 2014 - 2025 (USD Million)
21. UK pacemaker market, 2014 - 2025 (USD Million)
22. Germany pacemaker market, 2014 - 2025 (USD Million)
23. Asia Pacific pacemaker market, 2014 - 2025 (USD Million)
24. Japan pacemaker market, 2014 - 2025 (USD Million)
25. China pacemaker market, 2014 - 2025 (USD Million)
26. Latin America pacemaker market, 2014 - 2025 (USD Million)
27. Brazil pacemaker market, 2014 - 2025 (USD Million)
28. Mexico pacemaker market, 2014 - 2025 (USD Million)
29. MEA pacemaker market, 2014 - 2025 (USD Million)
30. South Africa pacemaker market, 2014 - 2025 (USD Million)
31. Saudi Arabia pacemaker market, 2014 - 2025 (USD Million)
1. Market summary
2. Market trends & outlook
3. Market segmentation & scope
4. Market driver relevance analysis (Current & Future Impact)
5. Market restraint relevance analysis (Current & Future Impact)
6. Penetration & growth prospect mapping
7. Healthcare predictive analytics PEST by SWOT analysis
8. Porter’s five forces analysis
9. Pacemaker market application outlook key takeaways
10. Pacemaker: Product movement analysis
11. Implantable pacemaker market 2014 - 2025 (USD Million)
12. Single chambered pacemaker market 2014 - 2025 (USD Million)
13. Dual chamber pacemaker market 2014 - 2025 (USD Million)
14. Biventricular pacemaker market 2014 - 2025 (USD Million)
15. Regional market place: Key takeaways
16. Regional outlook, 2015 & 2025
17. North America pacemaker market, 2014 - 2025 (USD Million)
18. U.S. pacemaker market, 2014 - 2025 (USD Million)
19. Canada pacemaker market, 2014 - 2025 (USD Million)
20. Europe pacemaker market, 2014 - 2025 (USD Million)
21. UK pacemaker market, 2014 - 2025 (USD Million)
22. Germany pacemaker market, 2014 - 2025 (USD Million)
23. Asia Pacific pacemaker market, 2014 - 2025 (USD Million)
24. Japan pacemaker market, 2014 - 2025 (USD Million)
25. China pacemaker market, 2014 - 2025 (USD Million)
26. Latin America pacemaker market, 2014 - 2025 (USD Million)
27. Brazil pacemaker market, 2014 - 2025 (USD Million)
28. Mexico pacemaker market, 2014 - 2025 (USD Million)
29. MEA pacemaker market, 2014 - 2025 (USD Million)
30. South Africa pacemaker market, 2014 - 2025 (USD Million)
31. Saudi Arabia pacemaker market, 2014 - 2025 (USD Million)
